Page last updated: 2024-08-21

4-trifluoromethylaniline and Fanconi Anemia

4-trifluoromethylaniline has been researched along with Fanconi Anemia in 1 studies

*Fanconi Anemia: Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blafkova, J; Cmejla, R; Jelinek, J; Petrtylova, K; Pospisilova, D; Stopka, T1

Other Studies

1 other study(ies) available for 4-trifluoromethylaniline and Fanconi Anemia

ArticleYear
Ribosomal proteins S3a, S13, S16, and S24 are not mutated in patients with Diamond-Blackfan anemia.
    Blood, 2001, Jan-15, Volume: 97, Issue:2

    Topics: Aniline Compounds; Eukaryotic Initiation Factor-2; Fanconi Anemia; Humans; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Proteins; RNA; Sequence Analysis, DNA

2001